Burning mouth syndrome (BMS) is a condition that remains a diagnostic challenge and is frequently difficult to treat. Rather than being a singular entity, more recent research has suggested that the diagnosis of BMS encompasses a family of syndromes. Of this family, type 3 has been identified as being related to contact dermatitis. Although this subtype has been most commonly associated with dental allergens, several food, cosmetic, and pharmaceutical products have also been identified as allergens related to the onset of BMS. Failure to identify these allergens prevents timely diagnosis and initiation of treatment for patients with BMS related to contact dermatitis. This article identifies the allergens most relevant to this type 3 and describes the commercially available allergy panels needed to ensure that all relevant allergens are included during patch testing. This study also describes approaches to diagnosis of BMS and discusses approaches to treatment based on subtypes of the condition.
Get full access to this article
View all access options for this article.
References
1.
MarinoR, CapaccioP, PignataroL, et al.Burning mouth syndrome: the role of contact hypersensitivity. Oral Dis, 2009; 15(4):255–258.
2.
Moghadam-KiaS, FazelN. A diagnostic and therapeutic approach to primary burning mouth syndrome. Clin Dermatol, 2017; 35(5):453–460.
GaoJ, ChenL, ZhouJ, et al.A case-control study on etiological factors involved in patients with burning mouth syndrome. J Oral Pathol Med, 2009; 38(1):24–28.
8.
MinicucciEM, PiresRB, VieiraRA, et al.Assessing the impact of menopause on salivary flow and xerostomia. Aust Dent J, 2013; 58(2):230–234.
9.
Dal SaccoD, GibelliD, GalloR. Contact allergy in the burning mouth syndrome: a retrospective study on 38 patients. Acta Derm Venereol, 2005; 85(1):63–64.
10.
DrageLA, RogersRS. Clinical assessment and outcome in 70 patients with complaints of burning or sore mouth symptoms. Mayo Clin Proc, 1999; 74(3):223–228.
11.
LameyPJ, LambAB. Occasional review prospective study of aetiological factors in burning mouth syndrome. Br Med J, 1988; 296:1243–1246.
12.
PetrykivS, De JongeL, ArtsM. Burning mouth syndrome: problem in the mouth?. Eur Psychiatry, 2018; 41(2017):S254.
13.
RaghavanSA, PuttaswamiahRN, BirurPN, et al.Antidepressant-induced burning mouth syndrome: a unique case. Korean J Pain, 2014; 27(3):294–296.
14.
MignognaMD, FedeleS, Lo RussoL, et al.The diagnosis of burning mouth syndrome represents a challenge for clinicians. J Orofac Pain, 2005; 19(2):168–173.
15.
Dutrée-MeulenbergRO, KozelMM, van JoostT. Burning mouth syndrome: a possible etiologic role for local contact hypersensitivity. J Am Acad Dermatol, 1992; 26(6):935–940.
16.
HeltonJ, StorrsF. The burning mouth syndrome: lack of a role for contact urticaria and contact dermatitis. J Am Acad Dermatol, 1994; 31(2):201–205.
17.
KaaberS, ThulinH, NielsenE. Skin sensitivity to denture base materials in the burning mouth syndrome. Contact Dermatitis, 1979; 5(2):90–96.
18.
SteeleJC, BruceAJ, DavisMDP, et al.Clinically relevant patch test results in patients with burning mouth syndrome. Dermatitis, 2012; 23(2):61–70.
19.
LyndeCB, GrushkaM, WalshSR. Burning mouth syndrome: patch test results from a large case series. J Cutan Med Surg, 2014; 18(3):174–179.
20.
AlankoK, KanervaL, JolankiR, et al.Oral mucosal diseases investigated by patch testing with a dental screening series. Contact Dermatitis, 1996; 34(4):263–267.
National Center for Biotechnology Information. Benzoyl Peroxide. PubChem Compund Database. Available at: https://pubchem.ncbi.nlm.nih.gov/compound/7187. Published 2005. Accessed June4, 2018.
32.
Agency for Toxic Substances and Disease Registry (ATSDR). Toxicological profile for Propylene Glycol. Atlanta, GA: U.S. Department of Health and Human Services, Public Health Service; 1997.
ForaboscoA, CriscuoloM, CoukosG, et al.Efficacy of hormone replacement therapy in postmenopausal women with oral discomfort. Oral Surg Oral Med Oral Pathol, 1992; 73(5):570–574.
35.
SunA, WuKM, WangYP, et al.Burning mouth syndrome: a review and update. J Oral Pathol Med, 2013; 42(9):649–655.
36.
CoculescuEC, RaduA, CoculescuBI. Burning mouth syndrome: a review on diagnosis and treatment. J Med Life, 2014; 7(4):512–515.
37.
FurnessS, WorthingtonHV, BryanG, et al.Interventions for the management of dry mouth: topical therapies. Cochrane Database Syst Rev, 2011; 12:CD008934.
38.
Gremeau-RichardC, WodaA, NavezML, et al.Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain, 2004; 108(1):51–57.
39.
de CastroLA, Ribeiro-RottaRF. The effect of clonazepam mouthwash on the symptomatology of burning mouth syndrome: an open pilot study. Pain Med, 2014; 15(12):2164–2165.
